Lee E. Schechter

6.6k total citations
95 papers, 5.3k citations indexed

About

Lee E. Schechter is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Lee E. Schechter has authored 95 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cellular and Molecular Neuroscience, 48 papers in Molecular Biology and 30 papers in Organic Chemistry. Recurrent topics in Lee E. Schechter's work include Neurotransmitter Receptor Influence on Behavior (38 papers), Receptor Mechanisms and Signaling (27 papers) and Neuroscience and Neuropharmacology Research (22 papers). Lee E. Schechter is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (38 papers), Receptor Mechanisms and Signaling (27 papers) and Neuroscience and Neuropharmacology Research (22 papers). Lee E. Schechter collaborates with scholars based in United States, Canada and France. Lee E. Schechter's co-authors include Sharon Rosenzweig‐Lipson, Jessica E. Malberg, Chad E. Beyer, Robert H. Ring, Deborah L. Smith, Menelas N. Pangalos, Terrance H. Andree, Orest Hurko, Kenneth J. Rhodes and Stacey J. Sukoff Rizzo and has published in prestigious journals such as Neuron, Journal of Neuroscience and The EMBO Journal.

In The Last Decade

Lee E. Schechter

95 papers receiving 5.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lee E. Schechter	2.6k	2.3k	849	676	672	95	5.3k
Linda P. Dwoskin	3.9k 1.5×	4.5k 2.0×	951 1.1×	551 0.8×	778 1.2×	259	7.6k
Gavin J. Kilpatrick	3.1k 1.2×	2.7k 1.2×	369 0.4×	491 0.7×	372 0.6×	83	6.4k
Jorge D. Brioni	2.5k 1.0×	3.3k 1.4×	572 0.7×	461 0.7×	981 1.5×	136	6.6k
Robert J. Naylor	2.9k 1.1×	2.0k 0.9×	416 0.5×	430 0.6×	518 0.8×	134	4.9k
Graeme R. Martin	3.6k 1.4×	3.0k 1.3×	556 0.7×	525 0.8×	475 0.7×	56	6.5k
Franco Borsini	3.5k 1.4×	2.0k 0.9×	324 0.4×	932 1.4×	933 1.4×	152	6.1k
R.J. Naylor	4.7k 1.8×	2.8k 1.2×	480 0.6×	690 1.0×	924 1.4×	174	8.1k
John Hyttel	4.8k 1.9×	3.2k 1.4×	561 0.7×	597 0.9×	1.1k 1.6×	113	7.3k
Mitsuhiko Yamada	1.7k 0.7×	1.5k 0.7×	361 0.4×	514 0.8×	545 0.8×	181	4.1k
Shigeyuki Chaki	3.9k 1.5×	2.5k 1.1×	450 0.5×	679 1.0×	2.2k 3.3×	185	7.5k

Countries citing papers authored by Lee E. Schechter

Since Specialization

Citations

This map shows the geographic impact of Lee E. Schechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee E. Schechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee E. Schechter more than expected).

Fields of papers citing papers by Lee E. Schechter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee E. Schechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee E. Schechter. The network helps show where Lee E. Schechter may publish in the future.

Co-authorship network of co-authors of Lee E. Schechter

This figure shows the co-authorship network connecting the top 25 collaborators of Lee E. Schechter. A scholar is included among the top collaborators of Lee E. Schechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee E. Schechter. Lee E. Schechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parks, Virginia, et al.. (2011). Concomitant blockade of 5-HT1A receptor and 5-HT transporter: Use of the Hunter Serotonin Toxicity Criteria in a clinical pharmacology study. European Neuropsychopharmacology. 22(2). 92–99. 5 indexed citations

Carr, Gregory V., Lee E. Schechter, & Irwin Lucki. (2010). Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats. Psychopharmacology. 213(2-3). 499–507. 71 indexed citations

Liu, Kevin G., Albert J. Robichaud, James F. Mattes, et al.. (2010). Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT6 antagonists. Bioorganic & Medicinal Chemistry. 19(1). 650–662. 19 indexed citations

Balu, Darrick T., et al.. (2008). Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Research. 1211. 37–43. 166 indexed citations

Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2008). A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 18(14). 3929–3931. 24 indexed citations

Zhou, Dahui, Ping Zhou, Deborah A. Evrard, et al.. (2008). Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives. Bioorganic & Medicinal Chemistry. 16(14). 6707–6723. 21 indexed citations

Deecher, Darlene C., et al.. (2007). From menarche to menopause: Exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology. 33(1). 3–17. 206 indexed citations

Beyer, Chad E., Qian Lin, Sharon Rosenzweig‐Lipson, & Lee E. Schechter. (2006). α2A-adrenoceptors enhance the serotonergic effects of fluoxetine. European Journal of Pharmacology. 539(3). 164–167. 9 indexed citations

Dunlop, John, Annmarie L. Sabb, Hossein Mazandarani, et al.. (2005). WAY-163909 [(7 bR, 10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity. Journal of Pharmacology and Experimental Therapeutics. 313(2). 862–869. 84 indexed citations

10.

Zhou, Dahui, Boyd L. Harrison, Terrance H. Andree, et al.. (2005). Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1338–1341. 43 indexed citations

11.

Schechter, Lee E., Daniel L. Smith, Sharon Rosenzweig‐Lipson, et al.. (2005). Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1274–1289. 107 indexed citations

12.

Kowal, Dianne, Jean Zhang, Stanley Nawoschik, et al.. (2002). The C-terminus of Gi family G-proteins as a determinant of 5-HT1A receptor coupling. Biochemical and Biophysical Research Communications. 294(3). 655–659. 17 indexed citations

13.

Meagher, Kristin L., Richard E. Mewshaw, Deborah A. Evrard, et al.. (2001). Studies towards the next generation of antidepressants. Part 1: indolylcyclohexylamines as potent serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(14). 1885–1888. 28 indexed citations

14.

Olsen, Michael A. & Lee E. Schechter. (1999). Cloning, mRNA localization and evolutionary conservation of a human 5-HT7 receptor pseudogene. Gene. 227(1). 63–69. 32 indexed citations

15.

Dunlop, John, Yingxin Zhang, Deborah L. Smith, & Lee E. Schechter. (1998). Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer. Journal of Pharmacological and Toxicological Methods. 40(1). 47–55. 33 indexed citations

16.

Rhodes, Kenneth J., Michael M. Monaghan, Nestor X. Barrezueta, et al.. (1996). Voltage-gated K+ channel beta subunits: expression and distribution of Kv beta 1 and Kv beta 2 in adult rat brain.. PubMed Central. 16(16). 4846–60. 131 indexed citations

17.

Shi, Gongyi, Kensuke Nakahira, Scott M. Hammond, et al.. (1996). βSubunits Promote K+ Channel Surface Expression through Effects Early in Biosynthesis. Neuron. 16(4). 843–852. 309 indexed citations

18.

Gozlan, H., et al.. (1994). Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33(3-4). 423–431. 40 indexed citations

19.

Zgombick, J M, Richard L. Weinshank, M Macchi, et al.. (1991). Expression and Pharmacological Characterization of a Canine 5-Hydroxytryptamine1D Receptor Subtype. Molecular Pharmacology. 40(6). 1036–1042. 48 indexed citations

20.

Hoyer, Daniël, et al.. (1989). Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?. European Journal of Pharmacology. 171(1). 137–139. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact